{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:45:32Z","timestamp":1780980332836,"version":"3.54.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,15]],"date-time":"2014-09-15T00:00:00Z","timestamp":1410739200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0107465","type":"journal-article","created":{"date-parts":[[2014,9,15]],"date-time":"2014-09-15T17:59:59Z","timestamp":1410803999000},"page":"e107465","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Initial Medication in Patients of Newly Diagnosed Parkinson\u2019s Disease in Taiwan"],"prefix":"10.1371","volume":"9","author":[{"given":"Yi-Jen","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Heng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,9,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases","volume":"55","author":"AJ Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson\u2019s disease: variation by age, gender, and race\/ethnicity","volume":"157","author":"SK Van Den Eeden","year":"2003","journal-title":"Am J Epidemiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/oxfordjournals.aje.a117721","article-title":"The frequency of idiopathic Parkinson\u2019s disease by age, ethnic group, and sex in northern Manhattan, 1988\u20131993","volume":"142","author":"R Mayeux","year":"1995","journal-title":"Am J Epidemiol"},{"key":"ref4","first-page":"106","article-title":"Clinical inquiry. Which drugs work best for early Parkinson\u2019s disease?","volume":"61","author":"L Jain","year":"2012","journal-title":"J Fam Pract"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/WCO.0b013e3283542fc2","article-title":"Therapies in Parkinson\u2019s disease","volume":"25","author":"J Jankovic","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.23829","article-title":"The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson\u2019s disease","volume":"26","author":"SH Fox","year":"2011","journal-title":"Mov Disord"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"JE Ahlskog","year":"2001","journal-title":"Mov Disord"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1212\/WNL.41.2_Part_1.202","article-title":"Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson\u2019s disease","volume":"41","author":"V Kostic","year":"1991","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mds.870020201","article-title":"Young onset Parkinson\u2019s disease","volume":"2","author":"N Quinn","year":"1987","journal-title":"Mov Disord"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.10609","article-title":"Slower progression of Parkinson\u2019s disease with ropinirole versus levodopa: The REAL-PET study","volume":"54","author":"AL Whone","year":"2003","journal-title":"Ann Neurol"},{"key":"ref11","first-page":"1044","article-title":"Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial","volume":"61","author":"RG Holloway","year":"2004","journal-title":"Arch Neurol"},{"key":"ref12","first-page":"229","article-title":"Levodopa in the treatment of Parkinson\u2019s disease: an old drug still going strong","volume":"5","author":"W Poewe","year":"2010","journal-title":"Clin Interv Aging"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3949\/ccjm.78gr.11005","article-title":"Updates in the medical management of Parkinson disease","volume":"79","author":"HH Fernandez","year":"2012","journal-title":"Cleve Clin J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"II25","DOI":"10.1007\/s00415-002-1205-3","article-title":"Initial therapy for Parkinson\u2019s disease: levodopa vs. dopamine receptor agonists","volume":"249","author":"T Kondo","year":"2002","journal-title":"J Neurol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1212\/WNL.58.suppl_1.S79","article-title":"Treatment of early Parkinson\u2019s disease","volume":"58","author":"WC Koller","year":"2002","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1212\/WNL.50.6_Suppl_6.S18","article-title":"Initiating therapy for Parkinson\u2019s disease","volume":"50","author":"DE Silver","year":"1998","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/practneurol-2011-000011","article-title":"The treatment of early Parkinson\u2019s disease: levodopa rehabilitated","volume":"11","author":"A Vlaar","year":"2011","journal-title":"Pract Neurol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/00207454.2011.620197","article-title":"Diagnosis and initiation of treatment in Parkinson\u2019s disease","volume":"121","author":"KE Lyons","year":"2011","journal-title":"Int J Neurosci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/practneurol-2012-000210","article-title":"Prescribing in Parkinson\u2019s disease: a story of hope and adverse events","volume":"12","author":"P Morrish","year":"2012","journal-title":"Pract Neurol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1212\/01.wnl.0000210433.49727.40","article-title":"Initial pharmacotherapy in a population of veterans with Parkinson disease","volume":"66","author":"K Swarztrauber","year":"2006","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/0891988706286512","article-title":"Patterns of initial pharmacotherapy for Parkinson\u2019s disease in the United States","volume":"19","author":"DM Huse","year":"2006","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eplepsyres.2011.05.003","article-title":"Trends in the use of antiepileptic drugs in Taiwan from 2003 to 2007: a population-based national health insurance study","volume":"96","author":"LP Hsieh","year":"2011","journal-title":"Epilepsy Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jcma.2012.08.020","article-title":"Utilization of statins and aspirin among patients with diabetes and hyperlipidemia: Taiwan, 1998\u20132006","volume":"75","author":"YC Lin","year":"2012","journal-title":"J Chin Med Assoc"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/11598540-000000000-00000","article-title":"Drug-induced parkinsonism in the elderly: incidence, management and prevention","volume":"29","author":"JL Lopez-Sendon","year":"2012","journal-title":"Drugs Aging"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"I11","DOI":"10.1007\/s00415-003-1102-2","article-title":"Differential diagnosis of parkinsonian syndromes: dynamics of time courses are essential","volume":"250","author":"L Lachenmayer","year":"2003","journal-title":"J Neurol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.amjopharm.2010.08.001","article-title":"Drug therapies for Parkinson\u2019s disease: A database analysis of patient compliance and persistence","volume":"8","author":"ML Tarrants","year":"2010","journal-title":"Am J Geriatr Pharmacother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/jama.284.15.1931","article-title":"Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group","volume":"284","author":"G Parkinson Study","year":"2000","journal-title":"JAMA"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/mds.21831","article-title":"Medication adherence and associated outcomes in medicare health maintenance organization-enrolled older adults with Parkinson\u2019s disease","volume":"23","author":"AS Kulkarni","year":"2008","journal-title":"Mov Disord"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/ageing\/afl175","article-title":"Non-completion of changes to prescribed medications in people with Parkinson\u2019s disease","volume":"36","author":"WT Ng","year":"2007","journal-title":"Age Ageing"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/mds.20602","article-title":"Suboptimal medication adherence in Parkinson\u2019s disease","volume":"20","author":"KA Grosset","year":"2005","journal-title":"Mov Disord"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0107465","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T03:42:55Z","timestamp":1540266175000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0107465"}},"subtitle":[],"editor":[{"given":"Alfonso","family":"Fasano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,15]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0107465","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,15]]}}}